HBIO
NASDAQ · Life Sciences Tools & Services
Harvard Bioscience Inc
$5.21
+0.34 (+6.98%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+586.2% upside
Low Target
$24.20
Average Target
$35.75
High Target
$46.73
Current Price
$5.21
Current
$5.21
$5.21
Target
$35.75
$35.75
$24.20
$35.75 avg
$46.73
Scenario Analysis
Bear Case
$24.20
364.5%
Low target
Base Case
$35.75
+586.2%
Avg target
Bull Case
$46.73
+796.9%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$9.46
-44.9% from high
52-Week Low
$2.81
+85.4% from low
Target vs 52W High
$35.75
+277.9% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 33 | 88% | $369.21 | -25.3% |
| DHR | Strong Buy | 30 | 87% | $158.11 | -17.1% |
| A | Buy | 29 | 72% | $64.69 | -43.5% |
| IQV | Strong Buy | 30 | 80% | $82.96 | -51.9% |
| MTD | Hold | 21 | 43% | $170.43 | -86.6% |
| ILMN | Hold | 28 | 54% | $169.36 | +33.7% |
| WAT | Buy | 28 | 57% | $189.60 | -36.8% |
| WST | Strong Buy | 23 | 78% | $136.24 | -46.1% |